| Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study AT Taher, KM Musallam, M Karimi, A El-Beshlawy, K Belhoul, S Daar, ... Blood, The Journal of the American Society of Hematology 115 (10), 1886-1892, 2010 | 457 | 2010 |
| β-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint V De Sanctis, C Kattamis, D Canatan, AT Soliman, H Elsedfy, M Karimi, ... Mediterranean journal of hematology and infectious diseases 9 (1), 2017 | 347 | 2017 |
| Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia: the ESCALATOR study A Taher, A El‐Beshlawy, MS Elalfy, K Al Zir, S Daar, D Habr, ... European journal of haematology 82 (6), 458-465, 2009 | 194 | 2009 |
| Cytokine profile of sickle cell disease in Oman A Pathare, S Al Kindi, AA Alnaqdy, S Daar, H Knox‐Macaulay, ... American journal of hematology 77 (4), 323-328, 2004 | 189 | 2004 |
| Splenectomy and thrombosis: the case of thalassemia intermedia AT Taher, KM Musallam, M Karimi, A El‐Beshlawy, K Belhoul, S Daar, ... Journal of Thrombosis and Haemostasis 8 (10), 2152-2158, 2010 | 169 | 2010 |
| Age‐related complications in treatment‐naive patients with thalassaemia intermedia AT Taher, KM Musallam, A El‐Beshlawy, M Karimi, S Daar, K Belhoul, ... British journal of haematology 150 (4), 486-489, 2010 | 158 | 2010 |
| Multicenter validation of spin‐density projection‐assisted R2‐MRI for the noninvasive measurement of liver iron concentration TG St Pierre, A El‐Beshlawy, M Elalfy, A Al Jefri, K Al Zir, S Daar, D Habr, ... Magnetic resonance in medicine 71 (6), 2215-2223, 2014 | 135 | 2014 |
| Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload S Daar, AV Pathare Annals of hematology 85, 315-319, 2006 | 131 | 2006 |
| Cytokines in sickle cell disease A Pathare, SA Kindi, S Daar, D Dennison Hematology 8 (5), 329-337, 2003 | 114 | 2003 |
| Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates S Alkindi, S Al Zadjali, A Al Madhani, S Daar, H Al Haddabi, Q Al Abri, ... Hemoglobin 34 (2), 135-144, 2010 | 102 | 2010 |
| Reduction in labile plasma iron during treatment with deferasirox, a once‐daily oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia S Daar, A Pathare, H Nick, U Kriemler‐Krahn, A Hmissi, D Habr, A Taher European journal of haematology 82 (6), 454-457, 2009 | 89 | 2009 |
| Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis. JM White, BS Christie, D Nam, S Daar, DR Higgs Journal of medical genetics 30 (5), 396-400, 1993 | 84 | 1993 |
| International survey of T2* cardiovascular magnetic resonance in β-thalassemia major JP Carpenter, M Roughton, DJ Pennell, ... Haematologica 98 (9), 1368, 2013 | 80 | 2013 |
| Risk factors for pulmonary hypertension in patients with β thalassemia intermedia M Karimi, KM Musallam, MD Cappellini, S Daar, A El-Beshlawy, K Belhoul, ... European Journal of Internal Medicine 22 (6), 607-610, 2011 | 79 | 2011 |
| Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study KM Musallam, MD Cappellini, S Daar, M Karimi, A El-Beshlawy, ... Haematologica 99 (11), e218, 2014 | 75 | 2014 |
| A community-based study of common hereditary blood disorders in Oman AA Al Riyami, AJ Suleiman, M Afifi, ZM Al Lamki, S Daar EMHJ-Eastern Mediterranean Health Journal, 7 (6), 1004-1011, 2001, 2001 | 74 | 2001 |
| Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major A Pathare, A Taher, S Daar Annals of hematology 89, 405-409, 2010 | 71 | 2010 |
| Molecular characterization of G6PD deficiency in Oman S Daar, TJ Vulliamy, J Kaeda, PJ Mason, L Luzzatto Human heredity 46 (3), 172-176, 1996 | 70 | 1996 |
| Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-A study V De Sanctis, D Canatan, JLV Corrons, M Karimi, S Daar, C Kattamis, ... Mediterranean journal of hematology and infectious diseases 12 (1), 2020 | 56 | 2020 |
| Side effects of deferasirox iron chelation in patients with beta thalassemia major or intermedia M Al-Khabori, S Bhandari, M Al-Huneini, K Al-Farsi, V Panjwani, S Daar Oman Medical Journal 28 (2), 121, 2013 | 55 | 2013 |
